{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Los Angeles",
      "state": "CA",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "79327",
      "recalling_firm": "Bella All Natural",
      "address_1": "304 E 11th St",
      "address_2": "N/A",
      "postal_code": "90015-1715",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Product was distributed in California to online customers and retail stores.",
      "recall_number": "D-0593-2018",
      "product_description": "Bella Capsules, 600mg, 30-count bottles, Manufactured for: Bella All Natural 304 E 11th Street, Los Angeles, CA 90015",
      "product_quantity": "32 bottles",
      "reason_for_recall": "Marketed Without An Approved NDA/ANDA: This product contains undeclared sibutramine. The presence of sibutramine, a previously approved controlled substance that was withdrawn from the U.S. market in October 2010 due to safety concerns, in this tainted product renders it an unapproved drug for which safety and efficacy have not been established and therefore subject to recall.",
      "recall_initiation_date": "20180214",
      "center_classification_date": "20180313",
      "termination_date": "20190128",
      "report_date": "20180314",
      "code_info": "Lot #: MFD:10.15.2017, Exp.10/14/2019."
    }
  ]
}